| __timestamp | Amneal Pharmaceuticals, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 449634000 | 580006000 |
| Thursday, January 1, 2015 | 499226000 | 676585000 |
| Friday, January 1, 2016 | 597455000 | 778966000 |
| Sunday, January 1, 2017 | 526178000 | 671251000 |
| Monday, January 1, 2018 | 716403000 | 463508000 |
| Tuesday, January 1, 2019 | 352997000 | 445724000 |
| Wednesday, January 1, 2020 | 628393000 | 399725000 |
| Friday, January 1, 2021 | 768973000 | 296656000 |
| Saturday, January 1, 2022 | 784708000 | 293122000 |
| Sunday, January 1, 2023 | 820565000 | 268323000 |
| Monday, January 1, 2024 | 304979000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, Amneal Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. have showcased intriguing trends in their gross profits over the past decade. From 2014 to 2023, Amneal's gross profit surged by approximately 82%, peaking in 2023. In contrast, Taro experienced a decline of around 54% during the same period, with its lowest point in 2023. This divergence highlights the dynamic nature of the pharmaceutical industry, where strategic decisions and market conditions can lead to vastly different financial outcomes. Notably, Amneal's consistent growth reflects its robust market strategies, while Taro's challenges underscore the volatility and risks inherent in the sector. As we look to the future, the absence of data for Amneal in 2024 leaves room for speculation, while Taro shows signs of recovery. This comparison offers valuable insights for investors and industry analysts alike.
Johnson & Johnson vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Amgen Inc. vs Amneal Pharmaceuticals, Inc.
Gross Profit Comparison: Sanofi and Taro Pharmaceutical Industries Ltd. Trends
Gross Profit Trends Compared: Regeneron Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Gross Profit Trends Compared: GSK plc vs Amneal Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing United Therapeutics Corporation and Amneal Pharmaceuticals, Inc.
Gross Profit Comparison: Genmab A/S and Taro Pharmaceutical Industries Ltd. Trends
Gross Profit Analysis: Comparing Viatris Inc. and Taro Pharmaceutical Industries Ltd.
Jazz Pharmaceuticals plc and Amneal Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Pharming Group N.V. vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Lantheus Holdings, Inc. vs Amneal Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Amneal Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc.